
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
Meriem Hasmim, Yosra Messai, Linda Ziani, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 126
Meriem Hasmim, Yosra Messai, Linda Ziani, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
NK Cell Metabolism and Tumor Microenvironment
Iñigo Terrén, Ane Orrantia, Joana Vitallé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 361
Iñigo Terrén, Ane Orrantia, Joana Vitallé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 361
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 337
Yaojie Fu, Shanshan Liu, Shan Zeng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 337
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Linda Ziani, Salem Chouaı̈b, Jérôme Thiery
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 322
Linda Ziani, Salem Chouaı̈b, Jérôme Thiery
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 322
Immuno-Oncology: Emerging Targets and Combination Therapies
Henry T. Marshall, Mustafa B.A. Djamgoz
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 280
Henry T. Marshall, Mustafa B.A. Djamgoz
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 280
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity
Jing Ni, Xi Wang, Ana Stojanovic, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 1075-1087.e8
Open Access | Times Cited: 220
Jing Ni, Xi Wang, Ana Stojanovic, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 1075-1087.e8
Open Access | Times Cited: 220
Reactive oxygen species and cancer: A complex interaction
Sankaralingam Saikolappan, Binod Kumar, Gauri Shishodia, et al.
Cancer Letters (2019) Vol. 452, pp. 132-143
Closed Access | Times Cited: 213
Sankaralingam Saikolappan, Binod Kumar, Gauri Shishodia, et al.
Cancer Letters (2019) Vol. 452, pp. 132-143
Closed Access | Times Cited: 213
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
Soumaya Kouidhi, Farhat Ben Ayed, Amel Benammar Elgaaïed
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 166
Soumaya Kouidhi, Farhat Ben Ayed, Amel Benammar Elgaaïed
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 166
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Rongchen Shi, Yi‐Quan Tang, Hongming Miao
MedComm (2020) Vol. 1, Iss. 1, pp. 47-68
Open Access | Times Cited: 142
Rongchen Shi, Yi‐Quan Tang, Hongming Miao
MedComm (2020) Vol. 1, Iss. 1, pp. 47-68
Open Access | Times Cited: 142
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
Carin Dahlberg, Dhifaf Sarhan, Michael Chrobok, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 175
Carin Dahlberg, Dhifaf Sarhan, Michael Chrobok, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 175
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Role of Distinct Natural Killer Cell Subsets in Anticancer Response
Helena Stabile, Cinzia Fionda, Angela Gismondi, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 129
Helena Stabile, Cinzia Fionda, Angela Gismondi, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 129
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
José M. Ayuso, Regan Truttschel, Max M. Gong, et al.
OncoImmunology (2018) Vol. 8, Iss. 3, pp. 1553477-1553477
Open Access | Times Cited: 122
José M. Ayuso, Regan Truttschel, Max M. Gong, et al.
OncoImmunology (2018) Vol. 8, Iss. 3, pp. 1553477-1553477
Open Access | Times Cited: 122
Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
Monica Parodi, Federica Raggi, Davide Cangelosi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 119
Monica Parodi, Federica Raggi, Davide Cangelosi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 119
NK Cell-Based Immunotherapies in Cancer
Min Hwa Shin, Jung‐Hee Kim, Siyoung A. Lim, et al.
Immune Network (2020) Vol. 20, Iss. 2
Open Access | Times Cited: 119
Min Hwa Shin, Jung‐Hee Kim, Siyoung A. Lim, et al.
Immune Network (2020) Vol. 20, Iss. 2
Open Access | Times Cited: 119
Activation of immunosuppressive network in the aging process
Antero Salminen
Ageing Research Reviews (2019) Vol. 57, pp. 100998-100998
Closed Access | Times Cited: 118
Antero Salminen
Ageing Research Reviews (2019) Vol. 57, pp. 100998-100998
Closed Access | Times Cited: 118
Targeting Natural Killer Cells for Tumor Immunotherapy
Cai Zhang, Yuan Hu, Chongdeng Shi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 100
Cai Zhang, Yuan Hu, Chongdeng Shi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 100
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Dhifaf Sarhan, Keli L. Hippen, Amanda Lemire, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 7, pp. 766-775
Open Access | Times Cited: 95
Dhifaf Sarhan, Keli L. Hippen, Amanda Lemire, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 7, pp. 766-775
Open Access | Times Cited: 95
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4131-4131
Open Access | Times Cited: 92
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4131-4131
Open Access | Times Cited: 92
Stress and the nonsense-mediated RNA decay pathway
Alexandra Goetz, Miles Wilkinson
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 19, pp. 3509-3531
Open Access | Times Cited: 89
Alexandra Goetz, Miles Wilkinson
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 19, pp. 3509-3531
Open Access | Times Cited: 89
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Cai Zhang, Yuxia Liu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 74
Cai Zhang, Yuxia Liu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 74
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Ester Gonzalez‐Sanchez, Javier Vaquero, Maite G. Fernández‐Barrena, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3248-3248
Open Access | Times Cited: 62
Ester Gonzalez‐Sanchez, Javier Vaquero, Maite G. Fernández‐Barrena, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3248-3248
Open Access | Times Cited: 62
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 61
Yifei Zhu, Xinyan Li, Lei Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 61